Elucidation of Endothelial Cell Hemostatic Regulation with Integrin-Targeting Hydrogels
Despite advances in the development of materials for cardiovascular devices, current strategies generally lack the thromboresistance of the native endothelium both in terms of efficacy and longevity. To harness this innate hemostatic regulation and improve long-term hemocompatibility, biohybrid devices are designed to promote endothelialization. Much of the research effort to date has focused on the use of extracellular matrix (ECM)-mimics and coatings to promote endothelial cell adhesion and migration with less attention given to the effect of the supported ECM binding events on hemostatic regulation. In this study, we developed integrin-targeted hydrogels to investigate the individual and combined effects of integrin binding events supported by many ECM-based coatings (α1β1, α2β1, α5β1, αvβ3). Targeted endothelial cell integrin interactions were first confirmed with antibody blocking studies and then correlated with gene expression of hemostatic regulators and a functional assay of platelet attachment and activation. Surfaces that targeted integrins α1β1 and α2β1 resulted in an endothelial cell layer that exhibited a thromboresistant phenotype with an associated reduction in platelet attachment and activation. It is anticipated that identification of specific integrins that promote endothelial cell adhesion as well as thromboresistance will enable the design of cardiovascular materials with improved long-term hemocompatibility.
KeywordsEndothelial cells Integrins Hemostasis Thromboresistance Platelets
This work was funded by the National Institutes of Health, Grant Numbers R21 EB020978 and R01 EB013297. The authors kindly thank the Grande-Allen lab for their help in platelet adhesion studies.
Conflict of interest
Dr. Cosgriff-Hernandez reports a stakeholder interest in ECM Technologies, outside the submitted work; In addition, Dr. Cosgriff-Hernandez, Dr. Magnus Hook, and Dr. Brooke Russell have a patent US20110288274A1 issued, and a patent US9725498B2 issued. Dr. Hook and Dr. Russell are also stakeholders in ECM Technologies (ECMT) that seeks to commercialize designer collagens such as those used in the studies presented.
- 4.Bunch, T. J., H. T. May, T. L. Bair, B. G. Crandall, M. J. Cutler, J. D. Day, V. Jacobs, C. Mallender, J. S. Osborn, and S. M. Stevens. Atrial fibrillation patients treated with long-term warfarin anticoagulation have higher rates of all dementia types compared with patients receiving long-term warfarin for other indications. J. Am. Heart Assoc. 5:e003932, 2016.CrossRefPubMedCentralGoogle Scholar
- 7.Félétou, M. The endothelium, Part I: Multiple functions of the endothelial cells-focus on endothelium-derived vasoactive mediators. In: Colloquium Series on Integrated Systems Physiology: From Molecule to FunctionMorgan & Claypool Life Sciences, pp. 1–306, 2011.Google Scholar
- 10.Gillis-Haegerstrand, C., S. Frebelius, A. Haegerstrand, and J. Swedenborg. Cultured human endothelial cells seeded on expanded polytetrafluoroethylene support thrombin-mediated activation of protein C. J. Vasc. Surg. 24:226–234, 1996.Google Scholar
- 12.Hanson, S. R., H. F. Kotze, B. Savage, and L. A. Harker. Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Arterioscler. Thromb. Vasc. Biol. 5:595–603, 1985.Google Scholar
- 19.Munoz-Pinto, D. J., V. R. Guiza-Arguello, S. M. Becerra-Bayona, J. Erndt-Marino, S. Samavedi, S. Malmut, B. Russell, M. Höök, and M. S. Hahn. Collagen-mimetic hydrogels promote human endothelial cell adhesion, migration and phenotypic maturation. J. Mater. Chem. B 3:7912–7919, 2015.CrossRefPubMedCentralGoogle Scholar
- 26.van Hinsbergh, V. W. Endothelium—role in regulation of coagulation and inflammation. In: Seminars in Immunopathology, pp. 93–106, 2012.Google Scholar